RegWardenFDA facility compliance records
Recall

Class II — Terumo Cardiovascular Systems Corporation

Recalling firmTERUMO CARDIOVASCULAR SYSTEMS CORP.
Registered facilityTERUMO CARDIOVASCULAR SYSTEMS CORPORATION (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonMedical device used in cardiovascular procedures is defective.
ProductTerumo Pall AL6X Arterial Blood Line Filter, labeled in part Terumo Cardiovascular Systems Corporation, packaged as part of a Terumo Cardiovascular Procedure Kit or as a single, sterile filter unit Single/Sterile Terumo Pall AL6X Arterial Filter: The Terumo Pall AL6X Arterial Filter is indicated for use in cardiopulmonary bypass procedures for the removal of micro-emboli greater than 40 microns in size, including gas emboli, fat emboli and aggregates composed of platelets, red blood cells and other debris from the arterial line and where the flow rate will not exceed 8 liters per minute. Ca…
Quantity15,817 filters
DistributionNationwide Distribution including WA, IN, OK, TX, MI, CA, NY, CT, AZ, FL, WV, NC, VA, PA, TN, GA, AL, MA, SC, OH, MS, MO, SD, WI, AR, AND NV.
Initiated2013-07-26
Classified2013-09-20
Terminated2015-07-28
Recall numberZ-2261-2013
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Terumo Cardiovascular Systems Corporation (Z-2261-2013).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/65981/

Not open yet

Alerts for TERUMO CARDIOVASCULAR SYSTEMS CORP.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.